Surgical Science Sweden AB (publ) (SUS.ST)
SEK 154.5
(0.85%)
SEK 154.5
(0.85%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -581.1 Million SEK | -38.67% |
| 2022 | -419.05 Million SEK | -37.57% |
| 2021 | -304.6 Million SEK | -259.05% |
| 2020 | -84.83 Million SEK | -26.68% |
| 2019 | -66.97 Million SEK | -96.25% |
| 2018 | -34.12 Million SEK | 4.61% |
| 2017 | -35.77 Million SEK | -247.83% |
| 2016 | 24.2 Million SEK | 3.86% |
| 2015 | 23.3 Million SEK | 1668.31% |
| 2014 | 1.31 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -667.07 Million SEK | -1.2% |
| 2024 Q1 | -659.18 Million SEK | -13.44% |
| 2023 Q4 | -581.1 Million SEK | 4.12% |
| 2023 FY | -581.1 Million SEK | -38.67% |
| 2023 Q1 | -482.07 Million SEK | -15.04% |
| 2023 Q2 | -574.42 Million SEK | -19.15% |
| 2023 Q3 | -606.06 Million SEK | -5.51% |
| 2022 Q2 | -362.25 Million SEK | -9.8% |
| 2022 Q4 | -419.05 Million SEK | -13.22% |
| 2022 Q3 | -370.1 Million SEK | -2.17% |
| 2022 Q1 | -329.91 Million SEK | -8.31% |
| 2022 FY | -419.05 Million SEK | -37.57% |
| 2021 Q2 | -267.34 Million SEK | -1.37% |
| 2021 Q3 | -310.59 Million SEK | -16.18% |
| 2021 FY | -304.6 Million SEK | -259.05% |
| 2021 Q4 | -304.6 Million SEK | 1.93% |
| 2021 Q1 | -263.72 Million SEK | -210.86% |
| 2020 Q2 | -68.44 Million SEK | 0.17% |
| 2020 FY | -84.83 Million SEK | -26.68% |
| 2020 Q3 | -74.65 Million SEK | -9.07% |
| 2020 Q4 | -84.83 Million SEK | -13.64% |
| 2020 Q1 | -68.55 Million SEK | -2.37% |
| 2019 Q2 | -34.5 Million SEK | 0.42% |
| 2019 FY | -66.97 Million SEK | -96.25% |
| 2019 Q4 | -66.97 Million SEK | -34.32% |
| 2019 Q3 | -49.85 Million SEK | -44.52% |
| 2019 Q1 | -34.64 Million SEK | -1.52% |
| 2018 Q4 | -34.12 Million SEK | -26.86% |
| 2018 FY | -34.12 Million SEK | 4.61% |
| 2018 Q1 | -34.6 Million SEK | 3.29% |
| 2018 Q2 | -23.6 Million SEK | 31.79% |
| 2018 Q3 | -26.9 Million SEK | -13.98% |
| 2017 Q1 | 26.9 Million SEK | 11.16% |
| 2017 Q2 | -36.4 Million SEK | -235.32% |
| 2017 FY | -35.77 Million SEK | -247.83% |
| 2017 Q3 | -26.8 Million SEK | 26.37% |
| 2017 Q4 | -35.77 Million SEK | -33.49% |
| 2016 FY | 24.2 Million SEK | 3.86% |
| 2016 Q1 | 2.02 Million SEK | 0.0% |
| 2016 Q4 | 24.2 Million SEK | 0.0% |
| 2015 FY | 23.3 Million SEK | 1668.31% |
| 2014 FY | 1.31 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aino Health AB (publ) | -1.27 Million SEK | -45620.063% |
| Bonzun AB (publ) | 351 Thousand SEK | 165656.125% |
| Kontigo Care AB (publ) | -3.9 Million SEK | -14792.414% |
| Medhelp Care Aktiebolag (publ) | -8.26 Million SEK | -6930.877% |
| RaySearch Laboratories AB (publ) | 185.67 Million SEK | 412.964% |